v3.24.1.1.u2
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 65,218 $ 69,268
Marketable securities 202,384 264,413
Investment in equity securities 45,616 41,937
Accounts receivable 31,300 36,078
Prepaid expenses and other current assets 10,064 9,846
Total current assets 354,582 421,542
Property and equipment, net 20,630 21,940
Operating lease right-of-use assets 21,594 22,815
Marketable securities, non-current 0 0
Other non-current assets 5,739 3,567
Restricted cash 857 872
Total assets 403,402 470,736
Current liabilities:    
Accounts payable 7,511 9,440
Accrued compensation 7,077 14,686
Deferred revenue—current 20,502 20,666
Operating lease liability - current 6,673 6,420
Debt—current   4,061
Accrued expenses and other current liabilities 37,746 38,473
Total current liabilities 79,509 93,746
Deferred revenue - non-current 46,313 53,379
Operating lease liability - non-current 21,397 23,154
Deferred royalty obligation related to the sale of future royalties 156,465 149,114
Other non-current liabilities 1,694 1,694
Total liabilities 305,378 321,087
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value -10,000,000 shares authorized as of March 31, 2024 and December 31, 2023; no shares issued and outstanding as of March 31, 2024 and December 31, 2023
Common stock, $0.001 par value - 300,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 62,456,546 and61,009,829 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 62 61
Additional paid-in-capital 715,696 708,975
Accumulated other comprehensive income (loss) (113) 21
Accumulated deficit (617,621) (559,408)
Total stockholders’ equity 98,024 149,649
Total Liabilities and Stockholders’ Equity $ 403,402 $ 470,736

Source

10-Q PDF XBRL Zip